|
Play Video: The Importance of Insider Buying
|
|
|
The table below summarizes the most recent QSII insider buying information, with links below the price to see the
CAGR achieved by each insider on their purchases. As the saying goes on Wall St., there are many
possible reasons to sell a stock, but only one reason to buy. Watch the importance of insider buying video for more
information about why QSII insider buys are important for investors to follow.
Date | Insider | Price | Amount |
3-15-2018 Insider Buy |
James Robert Arnold Jr. Chief Financial Officer |
$13.10
CAGR »
|
$524,000.00 40,000 shares |
6-14-2016 Insider Buy |
James Robert Arnold Jr. Chief Financial Officer |
$12.02
CAGR »
|
$99,766.00 8,300 shares |
6-13-2016 Insider Buy |
Jeffrey H. Margolis Director |
$12.40
CAGR »
|
$124,000.00 10,000 shares |
12-9-2015 Insider Buy |
John R. Frantz CEO and President |
$15.45
CAGR »
|
$38,625.00 2,500 shares |
7-30-2014 Insider Buy |
Jocelyn Leavitt EVP, General Counsel/Secretary |
$15.30
CAGR »
|
$46,659.50 3,050 shares |
10-31-2013 Insider Buy |
Daniel Morefield EVP, Chief Operating Officer |
$22.91
CAGR »
|
$18,900.75 825 shares |
10-30-2013 Insider Buy |
Steve Puckett EVP, Chief Technology Officer |
$23.41
CAGR »
|
$55,013.50 2,350 shares |
9-10-2013 Insider Buy |
Morris Panner Director |
$21.20
CAGR »
|
$42,400.00 2,000 shares |
8-16-2013 Insider Buy |
James C. Malone Director |
$20.77
CAGR »
|
$41,540.00 2,000 shares |
6-13-2013 Insider Buy |
Mark H. Davis Director |
$17.96
CAGR »
|
$35,920.00 2,000 shares |
1-30-2013 Insider Buy |
Lance Rosenzweig Director |
$18.55
CAGR »
|
$37,100.00 2,000 shares |
7-31-2012 Insider Buy |
George H. Bristol Director |
$16.02
CAGR »
|
$160,200.00 10,000 shares |
7-31-2012 Insider Buy |
Russell Pflueger Director |
$16.06
CAGR »
|
$160,600.00 10,000 shares |
6-13-2012 Insider Buy |
Steve Puckett EVP Hospital Solutions |
$27.59
CAGR »
|
$34,487.50 1,250 shares |
11-3-2010 Insider Buy |
Maureen Spivack Director |
$62.91
CAGR »
|
$62,907.10 1,000 shares |
Also See: Institutional Holders of QSII
Also See: SEC filings
Below we present the annualized performance delivered by QSII stock since 3-15-2018 (the date of the most recent
insider purchase). The performance of the investment from the time QSII insider buying occurred is the ultimate
test of whether insiders were right about QSII being a good buy.
Growth of $10,000.00
Without Dividends Reinvested
|
Start date: |
03/16/2018 |
|
End date: |
09/07/2018 |
|
Start price/share: |
$13.53 |
|
End price/share: |
$22.35 |
|
Dividends collected/share: |
$0.00 |
|
Total return: |
65.19% |
|
Annualized Gain: |
135.96% |
|
Starting investment: |
$10,000.00 |
|
Ending investment: |
$16,519.00 |
|
Years: |
0.48 |
|
QSII Insider Buying
This Holdings Channel page has presented insider buying activity, covering Directors, officers (such as CEO, CFO, COO, etc.),
and >10% owners (who are required to file form 4's with the SEC). Important institutional owners may not fall under these
categories, but instead file their holdings quarterly on the latest form 13F filings.
While recent QSII insider buying activity is included, there may also be stock sales over this same period (Also See: SEC filings for sales and other details).
Also See: Funds Holding QSII
|
|